FI982733L - Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia - Google Patents

Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia Download PDF

Info

Publication number: FI982733L
Authority: FI; Finland
Prior art keywords: soluble compositions; triphenylethylene antiestrogens; triphenylethylene; antiestrogens; soluble
Prior art date: 1998-12-17

Application number

FI982733A

Other languages

English (en)

Swedish (sv)

Other versions

FI982733A0 (fi

Inventor

Ursin Kaija Af

Jukka Salmia

Heikki Niskanen

Pirjo Kortesuo

Mikko Kananen

Gunilla Oern

Juha Kiesvaara

Original Assignee

Orion Yhtymae Oyj

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-17

Filing date

1998-12-17

Publication date

2000-06-18

1998-12-17 Application filed by Orion Yhtymae Oyj filed Critical Orion Yhtymae Oyj

1998-12-17 Priority to FI982733A priority Critical patent/FI982733L/fi

1998-12-17 Publication of FI982733A0 publication Critical patent/FI982733A0/fi

1999-12-16 Priority to ES99963614T priority patent/ES2272092T3/es

1999-12-16 Priority to NZ512270A priority patent/NZ512270A/xx

1999-12-16 Priority to DE69933388T priority patent/DE69933388T2/de

1999-12-16 Priority to IL14357599A priority patent/IL143575A0/xx

1999-12-16 Priority to US09/868,179 priority patent/US6632841B1/en

1999-12-16 Priority to PCT/FI1999/001046 priority patent/WO2000035485A1/en

1999-12-16 Priority to CA002355175A priority patent/CA2355175C/en

1999-12-16 Priority to AU19855/00A priority patent/AU767714B2/en

1999-12-16 Priority to EP99963614A priority patent/EP1140196B1/en

1999-12-16 Priority to JP2000587804A priority patent/JP4523167B2/ja

1999-12-16 Priority to AT99963614T priority patent/ATE340591T1/de

2000-06-18 Publication of FI982733L publication Critical patent/FI982733L/fi

2001-06-05 Priority to IL143575A priority patent/IL143575A/en

2001-06-06 Priority to NO20012793A priority patent/NO330251B1/no

2003-04-08 Priority to US10/408,321 priority patent/US6887888B2/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)
Dental Preparations (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Detergent Compositions (AREA)

FI982733A 1998-12-17 1998-12-17 Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia FI982733L (fi)

Priority Applications (15)

Application Number	Priority Date	Filing Date	Title
FI982733A FI982733L (fi)	1998-12-17	1998-12-17	Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
AT99963614T ATE340591T1 (de)	1998-12-17	1999-12-16	Pharmazeutische lösungen von triphenylethylen- antiöstrogenen
PCT/FI1999/001046 WO2000035485A1 (en)	1998-12-17	1999-12-16	Soluble compositions of triphenylethylene antiestrogens
AU19855/00A AU767714B2 (en)	1998-12-17	1999-12-16	Soluble compositions of triphenylethylene antiestrogens
DE69933388T DE69933388T2 (de)	1998-12-17	1999-12-16	Pharmazeutische Lösungen VON TRIPHENYLETHYLEN-ANTIÖSTROGENEN
IL14357599A IL143575A0 (en)	1998-12-17	1999-12-16	Soluble compositions of triphenylethylene antiestrogens
US09/868,179 US6632841B1 (en)	1998-12-17	1999-12-16	Soluble compositions of triphenylethylene antiestrogens
ES99963614T ES2272092T3 (es)	1998-12-17	1999-12-16	Soluciones farmaceuticas que comprenden antiestrogenos de triofeniletileno.
CA002355175A CA2355175C (en)	1998-12-17	1999-12-16	Soluble compositions of triphenylethylene antiestrogens
NZ512270A NZ512270A (en)	1998-12-17	1999-12-16	Soluble compositions of triphenylethylene antiestrogens
EP99963614A EP1140196B1 (en)	1998-12-17	1999-12-16	pharmaceutical solutions comprising triphenylethylene antiestrogens
JP2000587804A JP4523167B2 (ja)	1998-12-17	1999-12-16	トリフェニルエチレン型抗エストロゲンの水溶性組成物
IL143575A IL143575A (en)	1998-12-17	2001-06-05	Soluble compositions of triphenylethylene antiestrogens
NO20012793A NO330251B1 (no)	1998-12-17	2001-06-06	Farmasoytisk losning og fremgangsmater for fremstilling derav
US10/408,321 US6887888B2 (en)	1998-12-17	2003-04-08	Soluble compositions of triphenylethylene antiestrogens

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FI982733A FI982733L (fi)	1998-12-17	1998-12-17	Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia

Publications (2)

Publication Number	Publication Date
FI982733A0 FI982733A0 (fi)	1998-12-17
FI982733L true FI982733L (fi)	2000-06-18

Family

ID=8553138

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI982733A FI982733L (fi)	1998-12-17	1998-12-17	Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia

Country Status (13)

Country	Link
US (2)	US6632841B1 (fi)
EP (1)	EP1140196B1 (fi)
JP (1)	JP4523167B2 (fi)
AT (1)	ATE340591T1 (fi)
AU (1)	AU767714B2 (fi)
CA (1)	CA2355175C (fi)
DE (1)	DE69933388T2 (fi)
ES (1)	ES2272092T3 (fi)
FI (1)	FI982733L (fi)
IL (2)	IL143575A0 (fi)
NO (1)	NO330251B1 (fi)
NZ (1)	NZ512270A (fi)
WO (1)	WO2000035485A1 (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI982733L (fi) *	1998-12-17	2000-06-18	Orion Yhtymae Oyj	Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
US7964734B2 (en)	2002-09-30	2011-06-21	A/S Gea Farmaceutisk Fabrik	Raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
US7968532B2 (en) *	2003-12-15	2011-06-28	Besins Healthcare Luxembourg	Treatment of gynecomastia with 4-hydroxy tamoxifen
US7507769B2 (en) *	2004-03-22	2009-03-24	Laboratoires Besins International	Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
DK2373305T3 (en) *	2008-12-11	2017-05-15	Besins Healthcare Lu Sarl	TRANSDERMAL PHARMACEUTICAL COMPOSITIONS INCLUDING A SERM
WO2014043618A1 (en) *	2012-09-17	2014-03-20	Bind Therapeutics, Inc.	Process for preparing therapeutic nanoparticles
RU2682332C2 (ru)	2013-09-16	2019-03-19	Астразенека Аб	Терапевтические полимерные наночастицы и способы их получения и применения
EP3015453B1 (en) *	2014-10-28	2016-10-12	F.I.S.- Fabbrica Italiana Sintetici S.p.A.	Process for the preparation of Clomiphene
US10364212B2 (en)	2016-04-22	2019-07-30	F.I.S.—Fabbrica Italiana Sintetici S.p.A.	Process for the preparation of enclomiphene citrate having needle shaped crystal habit

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE293263C (fi)
FR2558373B1 (fr)	1984-01-20	1987-07-03	Mauvais Jarvis Pierre	Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
GB8604528D0 (en) *	1986-02-24	1986-04-03	Ici Plc	Therapeutic agents
ATE107643T1 (de)	1989-05-05	1994-07-15	Asta Medica Ag	Salze des azelastins mit verbesserter löslichkeit.
US5189212A (en) *	1990-09-07	1993-02-23	University Of Georgia Research Foundation, Inc.	Triarylethylene carboxylic acids with estrogenic activity
GB9126209D0 (en)	1991-12-10	1992-02-12	Orion Yhtymae Oy	Drug formulations for parenteral use
GB9207437D0 (en)	1992-04-03	1992-05-20	Orion Yhtymae Oy	Topical administration of toremifene and its metabolites
IT1263831B (it) *	1993-01-29	1996-09-04	Paolo Chiesi	Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
DE4407742C1 (de)	1994-03-08	1995-06-22	Hexal Pharma Gmbh	Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
US5441986A (en)	1994-07-19	1995-08-15	Pfizer Inc.	Estrogen agonists as remedies for prostate and cardiovascular diseases
AU723987B2 (en)	1996-08-28	2000-09-07	Eli Lilly And Company	Amorphous benzothiophenes, methods of preparation, and methods of use
CZ341297A3 (cs) *	1996-10-30	1998-05-13	Eli Lilly And Company	Způsob zlepšení léčby nebo profylaxe rakoviny prsu
US6114395A (en)	1996-11-15	2000-09-05	Pfizer Inc.	Method of treating atherosclerosis
ATE214269T1 (de)	1997-06-27	2002-03-15	Akzo Nobel Nv	Oral anzuwendende flüssige arzneilösung
AU1143899A (en) *	1997-11-10	1999-05-31	Novo Nordisk A/S	Transdermal delivery of 3,4-diarylchromans
FI982733L (fi) *	1998-12-17	2000-06-18	Orion Yhtymae Oyj	Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
FI109332B (fi) *	1998-12-17	2002-07-15	Orion Yhtymae Oyj	Toremifeenin liukoisia koostumuksia

1998
- 1998-12-17 FI FI982733A patent/FI982733L/fi unknown
1999
- 1999-12-16 IL IL14357599A patent/IL143575A0/xx active IP Right Grant
- 1999-12-16 WO PCT/FI1999/001046 patent/WO2000035485A1/en active IP Right Grant
- 1999-12-16 AT AT99963614T patent/ATE340591T1/de not_active IP Right Cessation
- 1999-12-16 US US09/868,179 patent/US6632841B1/en not_active Expired - Lifetime
- 1999-12-16 DE DE69933388T patent/DE69933388T2/de not_active Expired - Lifetime
- 1999-12-16 AU AU19855/00A patent/AU767714B2/en not_active Ceased
- 1999-12-16 NZ NZ512270A patent/NZ512270A/xx not_active IP Right Cessation
- 1999-12-16 ES ES99963614T patent/ES2272092T3/es not_active Expired - Lifetime
- 1999-12-16 EP EP99963614A patent/EP1140196B1/en not_active Expired - Lifetime
- 1999-12-16 CA CA002355175A patent/CA2355175C/en not_active Expired - Fee Related
- 1999-12-16 JP JP2000587804A patent/JP4523167B2/ja not_active Expired - Fee Related
2001
- 2001-06-05 IL IL143575A patent/IL143575A/en not_active IP Right Cessation
- 2001-06-06 NO NO20012793A patent/NO330251B1/no not_active IP Right Cessation
2003
- 2003-04-08 US US10/408,321 patent/US6887888B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU767714B2 (en)	2003-11-20
EP1140196A1 (en)	2001-10-10
ATE340591T1 (de)	2006-10-15
US20030181530A1 (en)	2003-09-25
NO20012793L (no)	2001-08-09
US6887888B2 (en)	2005-05-03
FI982733A0 (fi)	1998-12-17
NZ512270A (en)	2003-01-31
NO330251B1 (no)	2011-03-14
DE69933388D1 (de)	2006-11-09
AU1985500A (en)	2000-07-03
EP1140196B1 (en)	2006-09-27
US6632841B1 (en)	2003-10-14
JP2002532437A (ja)	2002-10-02
CA2355175C (en)	2008-07-15
NO20012793D0 (no)	2001-06-06
JP4523167B2 (ja)	2010-08-11
CA2355175A1 (en)	2000-06-22
IL143575A0 (en)	2002-04-21
WO2000035485A1 (en)	2000-06-22
IL143575A (en)	2006-12-10
DE69933388T2 (de)	2007-08-23
ES2272092T3 (es)	2007-04-16

Publication	Publication Date	Title
ID26549A (id)	2001-01-18	Komposisi-komposisi epotilon
ATE367793T1 (de)	2007-08-15	Schweisshemmende zusammensetzungen
EA199900373A3 (ru)	2000-08-28	Фармацевтические композиции
DE69919953D1 (de)	2004-10-14	Funktionelle zusammensetzungen
ATE339223T1 (de)	2006-10-15	Kombinierte impfstoffzusammensetzungen
DE69900634D1 (de)	2002-01-31	Shampoozusammensetzungen
ATE469550T1 (de)	2010-06-15	Antiparasitäre zusammensetzungen
DE69928933D1 (de)	2006-01-19	Strahlungshärtbare zusammensetzungen
IS2325B (is)	2007-12-15	Örgerðar samsetningar epleróns
AR023440A1 (es)	2002-09-04	Composiciones antitranspirantes
NO20014608L (no)	2001-10-31	Vekstfremmende sammensetninger
DE69929799D1 (de)	2006-04-20	Ultraviolettlicht absorbierende zusammensetzungen
ITMI991754A0 (it)	1999-08-04	Composizioni cosmetiche
DE69935172D1 (de)	2007-03-29	Imidosilan Zusammensetzungen
DE69903545D1 (de)	2002-11-21	Ölzusammensetzungen
PT1139764E (pt)	2005-09-30	Composicao adjuvante
ID29785A (id)	2001-10-11	Komposisi-komposisi sampo
DE60007731D1 (de)	2004-02-19	Schweisshemmende zusammensetzungen
DE60025624D1 (de)	2006-04-06	Farbstabile polyarylat enthaltende zusammensetzungen
ID27889A (id)	2001-05-03	Komposisi-komposisi kopolimer polisiklik
PT1124567E (pt)	2006-08-31	Composicoes tamponadas para dialise
FI982733L (fi)	2000-06-18	Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
FR2787721B1 (fr)	2001-02-02	Compositions extinctrices
ITMI20001695A0 (it)	2000-07-25	Procedimento per la preparazione di composizioni organico-sili-coniche.
EE04217B1 (et)	2004-02-16	Farmatseutilised kompositsioonid